• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    15.07 Up 0.26(1.76%) Mar 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:14.81
    Open:14.81
    Bid:N/A
    Ask:16.75 x 200
    1y Target Est:13.94
    Beta:2.04
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:14.75 - 15.15
    52wk Range:9.38 - 15.98
    Volume:679,766
    Avg Vol (3m):693,476
    Market Cap:803.41M
    P/E (ttm):N/A
    EPS (ttm):-1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MNTA

    Comparison

    Symbol% ChgMkt Cap
    MNTAUp 1.76%803.41M
    GSKUp 0.77%113.11B
    SNYUp 2.40%130.67B
    TEVADown 0.70%52.80B

    Key Statistics

    Forward P/E (1 yr):53.82
    P/S (ttm):15.11
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.85
    Quarterly EPS Est (Mar-15) :-0.45
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback